Developing Acid-Responsive Glyco-Nanoplatform Based Vaccines for Enhanced Cytotoxic T-lymphocyte Responses Against Cancer and SARS-CoV-2.
Adv Funct Mater
; 31(41): 2105059, 2021 Oct 08.
Article
em En
| MEDLINE
| ID: mdl-34512228
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Adv Funct Mater
Ano de publicação:
2021
Tipo de documento:
Article